Tenet Healthcare Raises FY2026 Adj EPS Guidance from $16.38-$18.68 to $20.30-$21.69 vs $17.88 Est; Raises FY2026 Sales Guidance from $21.500
Tenet Healthcare (NYSE: THC ) raises FY2026 Adj EPS guidance from $16.38-$18.68 to $20.30-$21.69 vs $17.88 analyst estimate. Raises FY2026 sales outlook from $21.500 billion-$22.300 billion to $21.900 billion-$22.500 billion vs $21.996 billion estimate.
Story updates
08:40:33 PM UTC
SquawkNews
Tenet Healthcare (NYSE: THC ) raises FY2026 GAAP EPS guidance from $22.94-$32.64 to $34.57-$36.43 vs $24.76 analyst estimate..
Tenet Healthcare (NYSE: THC ) raises FY2026 Adj EPS guidance from $16.38-$18.68 to $20.30-$21.69 vs $17.88 analyst estimate.
Raises FY2026 sales outlook from $21.500 billion-$22.300 billion to $21.900 billion-$22.500 billion vs $21.996 billion estimate.